-
1
-
-
0030888853
-
The serpin-proteinase complex revealed
-
Lawrence D.A. The serpin-proteinase complex revealed. Nat. Struct. Biol. 4:1997;339-341.
-
(1997)
Nat. Struct. Biol.
, vol.4
, pp. 339-341
-
-
Lawrence, D.A.1
-
2
-
-
0032185396
-
Plasminogen activator inhibitor-1: A common denominator in cardiovascular disease
-
Vaughan D.E. Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease. J. Invest. Med. 46:1998;370-376.
-
(1998)
J. Invest. Med.
, vol.46
, pp. 370-376
-
-
Vaughan, D.E.1
-
3
-
-
0033370347
-
Course of molecular hemostatic markers during and after different surgical procedures
-
Siemens H., Brueckner S., Hagelberg S., Wagner T., Schmucker P. Course of molecular hemostatic markers during and after different surgical procedures. J. Clin. Anesth. 11:1999;622-629.
-
(1999)
J. Clin. Anesth.
, vol.11
, pp. 622-629
-
-
Siemens, H.1
Brueckner, S.2
Hagelberg, S.3
Wagner, T.4
Schmucker, P.5
-
4
-
-
0026650622
-
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries
-
Schneiderman J., Sawdey M., Keeton M., Bordin G., Bernstein E., Dilley R., Loskutoff D. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA. 89:1992;6998-7002.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 6998-7002
-
-
Schneiderman, J.1
Sawdey, M.2
Keeton, M.3
Bordin, G.4
Bernstein, E.5
Dilley, R.6
Loskutoff, D.7
-
5
-
-
0037967300
-
Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling
-
Stefansson S., McMahon G., Petitclerc E., Lawrence D.A. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Curr. Pharm. Des. 9:2003;1545-1564.
-
(2003)
Curr. Pharm. Des.
, vol.9
, pp. 1545-1564
-
-
Stefansson, S.1
Mcmahon, G.2
Petitclerc, E.3
Lawrence, D.A.4
-
6
-
-
0034456495
-
Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1
-
Crandall D.L., Busler D.E., McHendry-Rinde B., Groeling T.M., Kral J.G. Autocrine regulation of human preadipocyte migration by plasminogen activator inhibitor-1. J. Clin. Endocrinol. Metab. 85:2000;2609-2614.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 2609-2614
-
-
Crandall, D.L.1
Busler, D.E.2
Mchendry-Rinde, B.3
Groeling, T.M.4
Kral, J.G.5
-
7
-
-
0023727550
-
Plasminogen activator inhibitor in plasma and platelets
-
Booth N., Simpson A., Croll A., Bennett B., MacGregor I.R. Plasminogen activator inhibitor in plasma and platelets. Br. J. Haematol. 70:1988;327-333.
-
(1988)
Br. J. Haematol.
, vol.70
, pp. 327-333
-
-
Booth, N.1
Simpson, A.2
Croll, A.3
Bennett, B.4
Macgregor, I.R.5
-
8
-
-
0028958184
-
Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro
-
Eitzman D., Fay W.P., Lawrence D.A., Francis-Chmura A., Shore J.D., Olson S.T., Ginsburg D. Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro. J. Clin. Invest. 95:1995;2416-2420.
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 2416-2420
-
-
Eitzman, D.1
Fay, W.P.2
Lawrence, D.A.3
Francis-Chmura, A.4
Shore, J.D.5
Olson, S.T.6
Ginsburg, D.7
-
9
-
-
0027135792
-
Plasminogen activator inhibitor-1 gene-deficient mice: Effects on hemostasis, thrombosis, and thrombolysis
-
Carmeliet P., Stassen J., Schoonjans L., Ream B., van den Oord J., De Mo M., Mulligan R., Collen D. Plasminogen activator inhibitor-1 gene-deficient mice: effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:1993;2756-2760.
-
(1993)
J. Clin. Invest.
, vol.92
, pp. 2756-2760
-
-
Carmeliet, P.1
Stassen, J.2
Schoonjans, L.3
Ream, B.4
Van Den Oord, J.5
De Mo, M.6
Mulligan, R.7
Collen, D.8
-
10
-
-
0345725987
-
Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
-
Farrehi P., Ozaki C., Carmeliet P., Fay W.P. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation. 97:1998;1002-1008.
-
(1998)
Circulation
, vol.97
, pp. 1002-1008
-
-
Farrehi, P.1
Ozaki, C.2
Carmeliet, P.3
Fay, W.P.4
-
11
-
-
0030997665
-
Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene
-
Fay W.P., Parker A., Condrey L., Shapiro A. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood. 90:1997;204-208.
-
(1997)
Blood
, vol.90
, pp. 204-208
-
-
Fay, W.P.1
Parker, A.2
Condrey, L.3
Shapiro, A.4
-
13
-
-
0025181049
-
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo
-
Quax P., van den Hoogen C., Verheijen J., Padro T., Zeheb R., Gelehrter T., van Berkel T., Kuiper J., Emeis J. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J. Biol. Chem. 265:1990;15560-15563.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 15560-15563
-
-
Quax, P.1
Van Den Hoogen, C.2
Verheijen, J.3
Padro, T.4
Zeheb, R.5
Gelehrter, T.6
Van Berkel, T.7
Kuiper, J.8
Emeis, J.9
-
15
-
-
0030610091
-
ab fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis
-
ab fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis. Thromb. Haemost. 77:1997;964-969.
-
(1997)
Thromb. Haemost.
, vol.77
, pp. 964-969
-
-
Vangiezen, J.1
Wahlund, G.2
Nerme, V.3
Abrahamsson, T.4
-
16
-
-
0029894647
-
Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity
-
Charlton P., Faint R., Bent F., Bryans J., Chicarelli-Robinson I., Mackie I., Machin S., Bevan P. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb. Haemost. 75:1996;808-815.
-
(1996)
Thromb. Haemost.
, vol.75
, pp. 808-815
-
-
Charlton, P.1
Faint, R.2
Bent, F.3
Bryans, J.4
Chicarelli-Robinson, I.5
Mackie, I.6
Machin, S.7
Bevan, P.8
-
17
-
-
0034672348
-
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
-
Eitzman D., Westrick R., Xu Z., Tyson J., Ginsburg D. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood. 96:2000;4212-4215.
-
(2000)
Blood
, vol.96
, pp. 4212-4215
-
-
Eitzman, D.1
Westrick, R.2
Xu, Z.3
Tyson, J.4
Ginsburg, D.5
-
18
-
-
0035432902
-
Disruption of the plasminogen activator inhibitor-1 gene reduces adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice
-
Schafer K., Fujisawa K., Konstantinides S., Loskutoff D. Disruption of the plasminogen activator inhibitor-1 gene reduces adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. FASEB J. 15:2001;1840-1842.
-
(2001)
FASEB J.
, vol.15
, pp. 1840-1842
-
-
Schafer, K.1
Fujisawa, K.2
Konstantinides, S.3
Loskutoff, D.4
-
19
-
-
0036230414
-
Elevated levels of acute-phase proteins and the plasminogen activator inhibitor-1 predict the development of type 2 diabetes
-
Festa A., D'Agostino R., Tracy R., Haffner S. Elevated levels of acute-phase proteins and the plasminogen activator inhibitor-1 predict the development of type 2 diabetes. Diabetes. 51:2002;1131-1137.
-
(2002)
Diabetes
, vol.51
, pp. 1131-1137
-
-
Festa, A.1
D'agostino, R.2
Tracy, R.3
Haffner, S.4
-
20
-
-
0037069779
-
Prediction of the risk of myocardial infarction from polymorphisms in candidate genes
-
Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., Sone T., Tanaka M., Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N. Engl. J. Med. 347:2002;1916-1923.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 1916-1923
-
-
Yamada, Y.1
Izawa, H.2
Ichihara, S.3
Takatsu, F.4
Ishihara, H.5
Hirayama, H.6
Sone, T.7
Tanaka, M.8
Yokota, M.9
|